[Featured Stock] Bridge Biotherapeutics Shows Early Morning Strength

Bridge Biotherapeutics is showing strong early gains.

As of 9:06 AM on the 16th, Bridge Biotherapeutics is trading on the KOSDAQ market at 2,515 KRW, up 300 KRW (13.54%) from the previous trading day.

Bridge Bio is in the process of raising funds in the 20 billion KRW range through a rights offering with a dilution ratio of approximately 49%. Through this capital increase, the company plans to proactively secure costs to accelerate the development of new drug candidates and resolve financial uncertainties.